Neurobehavioral effects of treatment for opiate withdrawal

M G Coyle1, A Ferguson, L Lagasse

  • 1Department of Pediatrics, Brown Medical School, Women & Infants Hospital, 101 Dudley Street, Providence, Rhode Island 02905-2401, USA. coylem@southcoast.org

Insights

Adding phenobarbital to diluted tincture of opium (DTO) treatment significantly improved neurobehavioral scores in opiate-exposed infants. This dual treatment enhanced infant interaction, movement, and stress levels during early recovery.

Area of Science:

  • Neonatal Abstinence Syndrome
  • Neurobehavioral Development
  • Pharmacological Interventions

Background:

  • Infants exposed to opiates in utero often experience Neonatal Abstinence Syndrome (NAS).
  • Current treatments for NAS, such as diluted tincture of opium (DTO), aim to manage withdrawal symptoms.
  • The potential benefits of adjunctive therapies to DTO for improving infant neurobehavior require further investigation.

Purpose of the Study:

  • To evaluate the efficacy of combined diluted tincture of opium (DTO) and phenobarbital therapy.
  • To compare neurobehavioral outcomes in opiate-exposed infants receiving dual treatment versus DTO alone.
  • To determine if combined therapy accelerates recovery from neonatal opiate withdrawal.

Main Methods:

  • A partially randomized controlled trial was conducted.
  • Infants were assigned to receive either DTO alone or DTO in combination with phenobarbital.
  • Neurobehavioral assessments were performed during the initial three weeks of life.

Main Results:

  • Infants receiving DTO and phenobarbital (n=17) demonstrated significantly better neurobehavioral scores compared to those receiving DTO alone (n=15).
  • The dual-treatment group exhibited increased interactivity, smoother motor function, and reduced stress.
  • These improvements suggest enhanced neurobehavioral organization in the first three weeks post-birth.

Conclusions:

  • Combined DTO and phenobarbital therapy improves neurobehavioral organization in opiate-exposed infants.
  • This dual treatment approach may facilitate a more rapid recovery from neonatal opiate withdrawal.
  • Further research is warranted to confirm these findings and optimize treatment protocols for NAS.

Related Concept Videos

Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...